NewsBenzingaEli Lilly Announces Results From New Analysis Showing Zepbound 10 Mg And 15 Mg, Dual GIP And GLP-1 Receptor Agonist, Delivered Greater Weight Loss Than Wegovy HD In Adults With Obesity Eli Lilly Announces Results From New Analysis Showing Zepbound 10 Mg And 15 Mg, Dual GIP And GLP-1 Receptor Agonist, Delivered Greater Weight Loss Than Wegovy HD In Adults With Obesity Benzinga 2026.09.29 11:07 (GMT+0) Open on Benzinga Other news Lean Groups Certify Claude-Assisted Riemann Proof Here are the top AI agents that can live in your text messages Coatue Management Bets on SK hynix Stock as Demand for HBM Chips Accelerates Target, Biotech Lead 5 Stocks Showing Strength In Brutal Market Morgan Stanley "Buys the Dip," Adding Nearly 800 Bitcoin to Lift Total Holdings to 12,448 BTC Ethereum co-founder Vitalik criticizes Netflix's new FTX-themed series, saying its portrayal of CZ may be racially discriminatory
Ethereum co-founder Vitalik criticizes Netflix's new FTX-themed series, saying its portrayal of CZ may be racially discriminatory